All Comments by Paul Coleman

  1. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
  2. Neuropathology of three clinical cases prospectively diagnosed as dementia with Lewy bodies.
  3. Alzheimer neuropathologic alterations in aged cognitively normal subjects.
  4. A population-based study on blood pressure and brain atrophy in 85-year-olds.
  5. Cytoarchitectonic alterations in the supramarginal gyrus of late onset Alzheimer's disease.
  6. Diabetes and dementia in long-term care.
  7. Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration.
  8. Cleavage of Alzheimer's amyloid precursor protein (APP) by secretases occurs after O-glycosylation of APP in the protein secretory pathway. Identification of intracellular compartments in which APP cleavage occurs without using toxic agents that interfere
  9. Ubiquitin, cellular inclusions and their role in neurodegeneration.
  10. High frequency of apolipoprotein E epsilon4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes.
  11. The Alzheimerization of aging: a brief update.
  12. Effect of Alzheimer's brain extracts on dynein immunoreactivity in PC12 cells.
  13. Pyramidal neuron loss is matched by ghost tangle increase in Guam parkinsonism-dementia hippocampus.
  14. Visual loss and getting lost in Alzheimer's disease.
  15. Hyperactivation of mitogen-activated protein kinase increases phospho-tau immunoreactivity within human neuroblastoma: additive and synergistic influence of alteration of additional kinase activities.